Study on Outcomes of Percutaneous Peritoneal Dialysis Catheter Insertions in Adults with End-stage Kidney Disease

What this Trial Is About

Researchers are studying patients with end-stage kidney disease who need peritoneal dialysis PD catheter insertion. The goal is to learn more about the outcomes of PD catheters inserted using a percutaneous method, which can be done at the bedside with local anesthesia, unlike the usual laparoscopic surgery that requires general anesthesia. This approach may help patients who cannot undergo general anesthesia or need urgent dialysis. The study is observational and aims to collect data from multiple centers to improve knowledge and skills in this technique. The study focuses on patients aged over 18 who receive percutaneous PD catheter insertion between March 2023 and March 2026 at participating centers. The decision to use the percutaneous method rather than surgery is made by the treating doctor. Data is collected from patients starting four weeks before and up to twelve weeks after the catheter insertion. The study does not involve experimental treatments but tracks outcomes such as catheter function, complications, and dialysis use. Participants will provide demographic and clinical information, and complete quality of life questionnaires SF-12 and EQ5D-5L at the start and one year after catheter insertion. Researchers will monitor complications, catheter function, and dialysis usage over time, with follow-up lasting up to three years. The study also evaluates how well centers implement the percutaneous technique and gathers healthcare professionals feedback. Costs related to the procedure will be recorded immediately after insertion.

Percutaneous Peritoneal Dialysis Catheter Insertion (PREDICT)